Search
Products
Community
Markets
News
Brokers
More
EN
Get started
Markets
/
United Kingdom
/
Corporate bonds
/
GSK3981911
/
Analysis
G
G
G
GlaxoSmithKline Capital, Inc. 4.2% 18-MAR-2043
GSK3981911
FINRA
GSK3981911
FINRA
GSK3981911
FINRA
GSK3981911
FINRA
Market closed
Market closed
No trades
See on Supercharts
Overview
Analysis
GSK3981911 analysis
Overview
Coupon
Redemption
Risks
More
Key facts
Issuer
GlaxoSmithKline Capital, Inc.
Issue date
Mar 18, 2013
Maturity date
Mar 18, 2043
Outstanding amount
500.00 M
USD
Face value
1,000.00
USD
Minimum denomination
2,000.00
USD
Coupon
4.20% (Fixed)
Yield to maturity
5.91%
Acts as a financing subsidiary/Special purpose entity
Show more
Go deeper with bond data
Access the most important data for bonds including coupon rates, issue ratings, redemption data and more.
Start trial